It has been reported that clopidogrel enhances atorvastatin-induced mobilization of EPCs as demonstrated by the presence of CD34+/CD133+/KDR + cells in patients with coronary artery disease [29]. This evidence concerns the gene PROM1 and coronary artery disorder.